Lhotta K, Gehringer A, Jennings P, Kronenberg F, Brezinka C, Andersone I, Strazdins V
Department of Nephrology and Dialysis, Academic Teaching Hospital Feldkirch, Feldkirch, Austria.
Clin Nephrol. 2009 Jan;71(1):80-3. doi: 10.5414/cnp71080.
Familial juvenile hyperuricemic nephropathy (FJHN) is a rare autosomal dominant disease caused by mutations in the uromodulin gene (UMOD) and leading to gout, tubulointerstitial nephropathy and end-stage renal disease.
A Latvian family suffering from FJHN is described. The father of the family developed ESRD at age 36. His daughter was diagnosed with gout and chronic kidney disease at age 14 years. A renal biopsy revealed tubulointerstitial disease; 2 sons were diagnosed at age 9 and 4 with elevated uric acid levels and reduced fractional uric acid excretion. Urinary uromodulin was normal in the younger boy, but markedly decreased in the 2 other patients. Genetic analysis revealed a previously undescribed D196Y mutation in the UMOD gene. The female patient became pregnant at age 23. During pregnancy serum creatinine decreased from 2.0 to 1.5 mg/dl and blood pressure remained low. Analysis of the baby's umbilical cord blood and a mouth swab showed the presence of the D196Y mutation. Its urinary uromodulin excretion was in the low normal range.
The uromodulin excretion pattern observed in the investigated family suggests that urinary uromodulin decreases in FJHN from low normal values at childhood to extremely low levels in early adulthood. In addition, this first report on pregnancy in a patient with FJHN shows normal adaptation despite markedly reduced renal function.
家族性青少年高尿酸血症肾病(FJHN)是一种罕见的常染色体显性疾病,由尿调节蛋白基因(UMOD)突变引起,可导致痛风、肾小管间质性肾病和终末期肾病。
描述了一个患有FJHN的拉脱维亚家庭。该家庭的父亲在36岁时发展为终末期肾病。他的女儿在14岁时被诊断出患有痛风和慢性肾病。肾活检显示为肾小管间质性疾病;两个儿子分别在9岁和4岁时被诊断出血尿酸水平升高和尿酸排泄分数降低。年幼男孩的尿调节蛋白正常,但其他两名患者的尿调节蛋白明显降低。基因分析显示UMOD基因存在一个此前未描述的D196Y突变。该女性患者在23岁时怀孕。孕期血清肌酐从2.0降至1.5mg/dl,血压保持较低水平。对婴儿脐带血和口腔拭子的分析显示存在D196Y突变。其尿调节蛋白排泄处于低正常范围。
在所研究家庭中观察到的尿调节蛋白排泄模式表明,FJHN患者的尿调节蛋白从儿童期的低正常水平下降到成年早期的极低水平。此外,这篇关于FJHN患者怀孕的首例报告显示,尽管肾功能明显降低,但仍有正常的适应性变化。